| Tipifarnib studied in …STUDIED_INderived79 of 79show fewer |
|---|
| → studied in | NCT04997902Phase 1/Phase 2 · completed Combination Trial of Tipifarnib and Alpelisib in Adult Recurrent/ Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC) · 79 trials list this drug (3 active) | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06540963Phase 2 · recruiting Tipifarnib and Naxitamab for Relapsed/Refractory Neuroblastoma · 79 trials list this drug (3 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03155620Phase 2 · active not recruiting Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial) · 79 trials list this drug (3 active) | — | — | Hepatoblastoma,Malignant Germ Cell Tumor,Malignant Solid Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04284774Phase 2 · active not recruiting Tipifarnib for the Treatment of Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With HRAS Gene Alterations, a Pediatric MATCH Treatment Trial · 79 trials list this drug (3 active) | — | — | Hepatoblastoma,Malignant Germ Cell Tumor,Malignant Solid Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00093470Phase 3 · completed Tipifarnib in Treating Patients With Acute Myeloid Leukemia in Remission · 79 trials list this drug (3 active) | — | — | Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome,Myelodysplastic Syndrome with Excess Blasts,Adult Acute Megakaryoblastic Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04809233available Expanded Access to Tipifarnib · 79 trials list this drug (3 active) | — | — | Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00209989Phase 2 · completed Phase II Trial to Assess the Radiosensitizing Effect of ZARNESTRA in Patients With Glioblastoma Multiforme · 79 trials list this drug (3 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03496766Phase 2 · terminated Tipifarnib in Advanced Squamous NSCLC With Oncogen HRAS MutAtionS · 79 trials list this drug (3 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02807272Phase 2 · completed Tipifarnib in Subjects With Chronic Myelomonocytic Leukemia, Other MDS/MPN, and Acute Myeloid Leukemia · 79 trials list this drug (3 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02383927Phase 2 · completed Phase II Study of Tipifarnib in Squamous Head and Neck Cancer With HRAS Mutations · 79 trials list this drug (3 active) | — | — | Head and Neck Squamous Cell Carcinoma,Malignant Thyroid Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02464228Phase 2 · completed Investigation of Tipifarnib in Treatment of Subjects With Peripheral T-Cell Lymphoma (PTCL) That Have Not Responded to Standard Therapy · 79 trials list this drug (3 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03719690Phase 2 · completed Safety and Efficacy of Tipifarnib in Head and Neck Cancer With HRAS Mutations and Impact of HRAS on Response to Therapy · 79 trials list this drug (3 active) | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04865159Phase 1 · terminated Cardiovascular Safety Study of Tipifarnib in Patients With Advanced Solid Malignancies · 79 trials list this drug (3 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05693090Phase 1 · withdrawn Tipifarnib and Osimertinib in EGFR-mutated Non-Small Cell Lung Cancer · 79 trials list this drug (3 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02535650Phase 2 · unknown Study of Tipifarnib in Patients With Previously-Treated, Advanced, HRAS Mutant Urothelial Carcinoma · 79 trials list this drug (3 active) | — | — | Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00470301Phase 1/Phase 2 · completed Tipifarnib and Combination Chemotherapy in Treating Patients With Stage II or Stage III Breast Cancer · 79 trials list this drug (3 active) | — | — | Malignant Breast Neoplasm,Male Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00026104Phase 2 · completed Combination Chemotherapy Plus Radiation Therapy With or Without Tipifarnib in Treating Patients With Locally Advanced Pancreatic Cancer · 79 trials list this drug (3 active) | — | — | Malignant Pancreatic Neoplasm,Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00050986Phase 1/Phase 2 · completed Phase I/II Evaluation of Temozolomide and ZARNESTRA (R115777) for Recurrent and Progressive Glioblastoma Multiforme · 79 trials list this drug (3 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00077519Phase 1 · completed Tipifarnib and Radiation Therapy in Treating Patients With Unresectable Locally Advanced Pancreatic Cancer · 79 trials list this drug (3 active) | — | — | Malignant Pancreatic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00082888Phase 2 · completed Tipifarnib in Treating Patients With Relapsed or Refractory Lymphoma · 79 trials list this drug (3 active) | — | — | Anaplastic Large Cell Lymphoma,Non-Hodgkin Lymphoma,Adult Hodgkin Lymphoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00004009Phase 1 · completed R115777 in Treating Patients With Refractory or Recurrent Acute Leukemia or Chronic Myelogenous Leukemia · 79 trials list this drug (3 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00025480Phase 1 · completed Tipifarnib Plus Radiation Therapy After Combination Chemotherapy in Treating Patients With Stage III Non-Small Cell Lung Cancer · 79 trials list this drug (3 active) | — | — | Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00082810Phase 2 · completed Tipifarnib and Fulvestrant in Hormone Receptor-Positive Metastatic Breast Cancer · 79 trials list this drug (3 active) | — | — | Breast Neoplasm,Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00847223Phase 2 · terminated Efficacy and Safety of the Farnesyl-transferase Inhibitor (Tipifarnib) in Mantle Cell Lymphoma · 79 trials list this drug (3 active) | — | — | Mantle Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00335764Phase 1/Phase 2 · completed Sorafenib Combined With Erlotinib, Tipifarnib, or Temsirolimus in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma · 79 trials list this drug (3 active) | — | — | Adult Giant Cell Glioblastoma,Adult Glioblastoma,Adult Brain Neoplasm+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00005859Phase 1/Phase 2 · completed Tipifarnib in Treating Patients With Recurrent or Progressive Malignant Glioma · 79 trials list this drug (3 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02210858Phase 1/Phase 2 · completed Tipifarnib in Treating Patients With Chronic Myeloid Leukemia, Chronic Myelomonocytic Leukemia, or Undifferentiated Myeloproliferative Disorders · 79 trials list this drug (3 active) | — | — | Atypical Chronic Myeloid Leukemia,Chronic Myeloid Leukemia, BCR-ABL1 Positive,Chronic Myelomonocytic Leukemia+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00085553Phase 1 · completed Tipifarnib and Erlotinib Hydrochloride in Treating Patients With Advanced Solid Tumors · 79 trials list this drug (3 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00021541Phase 2 · completed R115777 to Treat Children With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas · 79 trials list this drug (3 active) | — | — | Plexiform Neurofibroma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00244972Phase 1 · completed Tipifarnib and Sorafenib Tosylate in Treating Patients With Biopsiable Advanced Cancer · 79 trials list this drug (3 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00360776Phase 2 · terminated Tipifarnib in Treating Patients With Anemia or Neutropenia and Large Granular Lymphocyte Leukemia · 79 trials list this drug (3 active) | — | — | Chronic Lymphocytic Leukemia,T-Cell Large Granular Lymphocyte Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00005832Phase 2 · completed S9924 R115777 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer · 79 trials list this drug (3 active) | — | — | Malignant Pancreatic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00047216Phase 2 · completed Tipifarnib in Treating Patients With Recurrent Bladder Cancer · 79 trials list this drug (3 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00101153Phase 1 · completed Tipifarnib, Cytarabine, and Daunorubicin in Treating Older Patients With Acute Myeloid Leukemia · 79 trials list this drug (3 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00070252Phase 1/Phase 2 · completed Neoadjuvant Tipifarnib, Docetaxel, and Capecitabine in Treating Patients With Locally Advanced or Metastatic Solid Tumors or Stage IIIA or Stage IIIB Breast Cancer · 79 trials list this drug (3 active) | — | — | Adult Solid Neoplasm,Malignant Breast Neoplasm,Male Breast Carcinoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00049387Phase 1 · completed Tipifarnib, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma · 79 trials list this drug (3 active) | — | — | Adult Giant Cell Glioblastoma,Adult Glioblastoma,Adult Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00383474Phase 1 · completed Tipifarnib and Bortezomib in Treating Patients With Acute Leukemia or Chronic Myelogenous Leukemia in Blast Phase · 79 trials list this drug (3 active) | — | — | Adult Acute Lymphoblastic Leukemia,Adult Acute Megakaryoblastic Leukemia,Adult Acute Myeloid Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01361464Phase 2 · completed Tipifarnib in Treating Older Patients With Acute Myeloid Leukemia · 79 trials list this drug (3 active) | — | — | Secondary Acute Myeloid Leukemia,Adult Acute Megakaryoblastic Leukemia,Adult Acute Myeloid Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00100750Phase 1/Phase 2 · completed Tipifarnib and Gemcitabine Hydrochloride in Treating Women With Metastatic Breast Cancer · 79 trials list this drug (3 active) | — | — | Malignant Breast Neoplasm,Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02227901Phase 1 · completed Tipifarnib, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme · 79 trials list this drug (3 active) | — | — | Adult Giant Cell Glioblastoma,Adult Glioblastoma,Adult Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00602771Phase 2 · completed Tipifarnib and Etoposide in Treating Older Patients With Newly Diagnosed, Previously Untreated Acute Myeloid Leukemia · 79 trials list this drug (3 active) | — | — | Secondary Acute Myeloid Leukemia,Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome,Adult Acute Megakaryoblastic Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00096122Phase 1/Phase 2 · completed Idarubicin, Cytarabine, and Tipifarnib in Treating Patients With Newly Diagnosed Myelodysplastic Syndromes or Acute Myeloid Leukemia · 79 trials list this drug (3 active) | — | — | Myelodysplastic Syndrome,Secondary Acute Myeloid Leukemia,Chronic Myelomonocytic Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00281957Phase 2 · completed Sorafenib With Either Temsirolimus or Tipifarnib in Treating Patients With Stage IV Malignant Melanoma That Cannot Be Removed By Surgery · 79 trials list this drug (3 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00079339Phase 1/Phase 2 · completed Tipifarnib and Radiation Therapy in Treating Young Patients With Brainstem Glioma · 79 trials list this drug (3 active) | — | — | Childhood Brain Stem Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00005845Phase 1 · completed Tipifarnib in Treating Patients With Myelodysplastic Syndromes · 79 trials list this drug (3 active) | — | — | Myelodysplastic Syndrome,Myelodysplastic Syndrome with Ring Sideroblasts,Chronic Myelomonocytic Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00006376Phase 2 · completed R115777 in Treating Patients With Advanced Bladder Cancer · 79 trials list this drug (3 active) | — | — | Bladder Neoplasm,Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00070525Phase 2 · completed Tipifarnib in Treating Young Patients With Recurrent or Progressive High-Grade Glioma, Medulloblastoma, Primitive Neuroectodermal Tumor, or Brain Stem Glioma · 79 trials list this drug (3 active) | — | — | Childhood Medulloblastoma,Childhood Brain Stem Glioma,Childhood Supratentorial Embryonal Tumor, Not Otherwise Specified+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00243035Phase 1/Phase 2 · terminated Tipifarnib and Bortezomib in Treating Patients With Relapsed Multiple Myeloma · 79 trials list this drug (3 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00454480Phase 2/Phase 3 · completed Combination Chemotherapy With or Without Gemtuzumab Ozogamicin or Tipifarnib in Treating Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes · 79 trials list this drug (3 active) | — | — | Leukemia,Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00005848Phase 2 · completed R115777 in Treating Patients With Progressive, Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy · 79 trials list this drug (3 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00052728Phase 2 · completed Tipifarnib Plus Tamoxifen in Treating Women With Metastatic Breast Cancer · 79 trials list this drug (3 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00049114Phase 2 · completed Tipifarnib, Doxorubicin, and Cyclophosphamide in Treating Women With Locally Advanced Breast Cancer · 79 trials list this drug (3 active) | — | — | Malignant Breast Neoplasm,Breast Inflammatory Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00060125Phase 2 · completed Tipifarnib in Treating Patients With Metastatic Malignant Melanoma · 79 trials list this drug (3 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00047190Phase 2 · completed Tipifarnib in Treating Patients With Myelofibrosis and Myeloid Metaplasia · 79 trials list this drug (3 active) | — | — | Essential Thrombocythemia,Polycythemia Vera,Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00055757Phase 2 · completed Tipifarnib, Gemcitabine, and Cisplatin in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer · 79 trials list this drug (3 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00124644Phase 1 · terminated Combination Chemotherapy and Tipifarnib in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia · 79 trials list this drug (3 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00025038Phase 2 · completed Combination Chemotherapy Followed By Donor Bone Marrow or Umbilical Cord Blood Transplant in Treating Children With Newly Diagnosed Juvenile Myelomonocytic Leukemia · 79 trials list this drug (3 active) | — | — | Juvenile Myelomonocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00058097Phase 2 · completed Tipifarnib and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme · 79 trials list this drug (3 active) | — | — | Adult Giant Cell Glioblastoma,Adult Glioblastoma,Adult Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00027872Phase 2 · completed Tipifarnib in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia · 79 trials list this drug (3 active) | — | — | Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome,Adult Acute Erythroid Leukemia,Adult Acute Megakaryoblastic Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00077363Phase 2 · completed Capecitabine and Tipifarnib in Treating Women With Taxane-Resistant Metastatic Breast Cancer · 79 trials list this drug (3 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00005842Phase 1 · completed Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer · 79 trials list this drug (3 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00005843Phase 2 · completed R115777 in Treating Patients Who Have Metastatic Pancreatic Cancer · 79 trials list this drug (3 active) | — | — | Malignant Pancreatic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00005967Phase 1 · completed Tipifarnib in Treating Patients With Advanced Hematologic Cancer · 79 trials list this drug (3 active) | — | — | Leukemia,Lymphoma,Myelodysplastic Syndrome+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00101296Phase 1 · completed Tipifarnib in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia · 79 trials list this drug (3 active) | — | — | Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome,Adult Acute Erythroid Leukemia,Adult Acute Megakaryoblastic Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00093418Phase 2 · completed S0432 Tipifarnib in Treating Older Patients With Acute Myeloid Leukemia · 79 trials list this drug (3 active) | — | — | Adult Acute Megakaryoblastic Leukemia,Adult Acute Myeloid Leukemia,Adult Acute Myeloid Leukemia with Maturation+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00045396Phase 2 · completed A Phase II Study Of The Farnesyltransferase Inhibitor ZANESTRA (R115777, NSC #702818, IND #58,359) In Complete Remission Following Induction And/Or Consolidation Chemotherapy In Adults With Poor-Risk Acute Myelogenous Leukemia (AML) And High-Risk Myelodysplasia (MDS) · 79 trials list this drug (3 active) | — | — | Adult Acute Myeloid Leukemia,Acute Myeloid Leukemia with del(5q),Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00112853Phase 1 · completed Tipifarnib and Etoposide in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia · 79 trials list this drug (3 active) | — | — | Secondary Acute Myeloid Leukemia,Adult Acute Megakaryoblastic Leukemia,Adult Acute Myeloid Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00005041Phase 2 · completed R115777 in Treating Patients With Relapsed Small Cell Lung Cancer · 79 trials list this drug (3 active) | — | — | Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00005990Phase 1 · completed R115777 Plus Topotecan in Treating Patients With Advanced Solid Tumors · 79 trials list this drug (3 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00040105Phase 1 · completed Zarnestra and Gleevec in Chronic Phase Chronic Myelogenous Leukemia · 79 trials list this drug (3 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00054470Phase 2 · withdrawn Tipifarnib Plus Trastuzumab in Treating Patients With Metastatic Breast Cancer · 79 trials list this drug (3 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003707Phase 1 · completed Combination Chemotherapy in Treating Patients With Advanced Cancer · 79 trials list this drug (3 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00005833Phase 2 · completed S9923 R115777 in Treating Patients With Advanced Colorectal Cancer · 79 trials list this drug (3 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00022451Phase 1 · completed Tipifarnib in Treating Young Patients With Refractory Leukemia · 79 trials list this drug (3 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00005989Phase 2 · completed R115777 in Treating Patients With Recurrent or Metastatic Non-small Cell Lung Cancer · 79 trials list this drug (3 active) | — | — | Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00354146Phase 2 · completed A Phase 2 Study of Farnesyl Transferase Inhibitor (R115777, Tipifarnib) in Patients With Refractory or Relapsed Acute Myeloid Leukemia. · 79 trials list this drug (3 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00025454Phase 1 · completed R115777 in Treating Patients With Advanced Solid Tumors · 79 trials list this drug (3 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00210028Phase 2 · terminated Study Assessing Efficacy of ZARNESTRA™ Combined With Tamoxifen in Patients With Advanced or Metastatic Breast Cancer · 79 trials list this drug (3 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00006199Phase 1 · unknown Study of the Farnesyl Transferase Inhibitor, R115777, in Combination With Topotecan (NYU 99-32) · 79 trials list this drug (3 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |